Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 19, Issue 3, Pages 337-339
Publisher
Wiley
Online
2017-01-20
DOI
10.1002/ejhf.742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
- (2016) Sanjiv J. Shah et al. CIRCULATION
- Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes
- (2016) Csaba Mátyás et al. EUROPEAN JOURNAL OF HEART FAILURE
- Reframing the association and significance of co-morbidities in heart failure
- (2016) Filippos Triposkiadis et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Emperor's New Clothes: PDE5 and the Heart
- (2015) Chantal V. Degen et al. PLoS One
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
- (2014) Karina Huynh et al. PHARMACOLOGY & THERAPEUTICS
- Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
- (2013) Nazha Hamdani et al. Circulation-Heart Failure
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
- (2013) Stephen J. Greene et al. Journal of the American Heart Association
- Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy
- (2012) Elisa Giannetta et al. CIRCULATION
- Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
- (2012) Loek van Heerebeek et al. CIRCULATION
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
- (2011) Marco Guazzi et al. CIRCULATION
- PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure
- (2010) Marco Guazzi et al. Circulation-Heart Failure
- Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5
- (2010) Manling Zhang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure
- (2008) Marco Guazzi Circulation-Heart Failure
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started